HONG KONG/BEIJING — Chinese mRNA vaccine developer Suzhou Abogen Biosciences is in talks with Japan’s SoftBank and other investors to raise $300 million-$400 million, people familiar with the matter said. Read More
Market SamplerMarket Sampler
Market SamplerAre you a Marketing Agency?
Find out why, and how to work together.
Find out what people like and dislike about your competitors, and compare it with your brand performance.